
Bitaz P 4000mg/500mg Injection
Marketer
Biosys Medisciences
Salt Composition
Piperacillin (4000mg) + Tazobactum (500mg)
Overview Bitaz P 4000mg/500mg Injection
The dual-antibiotic injection, Bitaz P (4000mg/500mg), combats diverse bacterial infections by eliminating microorganisms. Administered solely by medical personnel, its dosage and frequency are determined by a physician based on the patient's condition. Strict adherence to the prescribed regimen is crucial. Potential side effects may encompass nausea, vomiting, diarrhea, rash, and injection site reactions (pain, swelling, redness). Persistent or worsening side effects warrant immediate medical attention. Prior to treatment, disclose any antibiotic allergies, kidney, or liver issues to your doctor; adjustments to dosage or alternative medications may be necessary. While generally safe during pregnancy and lactation under medical guidance, professional supervision is essential.
Uses of Bitaz P 4000mg/500mg Injection
Infections caused by bacteria
Major Benefits of Bitaz P 4000mg/500mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Bitaz P 4000mg/500mg Injection:
- Nausea
- Vomiting
- Diarrhea
- Rash
- Allergic reaction
How to use Bitaz P 4000mg/500mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.
How Bitaz P 4000mg/500mg Injection works:
The injectable formulation, Bitaz P 4000mg/500mg, unites Piperacillin, a bacterial growth inhibitor, with Tazobactum, a beta-lactamase inhibitor. Piperacillin's mechanism involves disrupting essential bacterial cell wall synthesis, thereby halting bacterial proliferation. Tazobactum complements this action by counteracting bacterial resistance mechanisms, thus optimizing Piperacillin's antimicrobial effect.
SAFETY ADVICE
AlcoholSAFE
Alcohol consumption alongside Bitaz P 4000mg/500mg Injection poses no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Bitaz P (4000mg/500mg) is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or no negative consequences for fetal development; however, clinical data from human trials are currently scarce.
Breast feedingSAFE IF PRESCRIBED
The injectable medication Bitaz P (4000mg/500mg) poses no known breastfeeding risk. Research in humans indicates negligible transfer to breast milk, rendering it unlikely to harm the infant.
DrivingCONSULT YOUR DOCTOR
The impact of Bitaz P 4000mg/500mg Injection on driving ability is undetermined. Refrain from driving if you exhibit symptoms impairing concentration or reaction time.
KidneyCAUTION
For individuals with kidney impairment, the administration of Bitaz P 4000mg/500mg Injection requires careful monitoring. Dosage modification of Bitaz P 4000mg/500mg Injection might be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
The use of Bitaz P 4000mg/500mg Injection in patients with hepatic impairment appears to present a low risk. Preliminary findings indicate dose modification may be unnecessary; however, medical consultation is advised.
What if you forget to take Bitaz P 4000mg/500mg Injection :
Omitting a scheduled dose of Bitaz P 4000mg/500mg Injection requires immediate physician consultation.
Facts to Know About Bitaz P 4000mg/500mg Injection
| Label | Value |
|---|---|
| Potential for Dependence | None. |
| Type of Medication | Agents against infection |
